|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
|
JP2623099B2
(ja)
|
1987-11-06 |
1997-06-25 |
株式会社ニフコ |
スライダの引込み装置
|
|
US5202128A
(en)
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
DK469989D0
(da)
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
|
US5221536A
(en)
|
1990-05-07 |
1993-06-22 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
|
US5190763A
(en)
|
1990-05-07 |
1993-03-02 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
|
DE4225730C2
(de)
|
1992-08-04 |
2003-04-30 |
Merz Pharma Gmbh & Co Kgaa |
Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
|
|
US5358721A
(en)
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
|
AUPN605795A0
(en)
|
1995-10-19 |
1995-11-09 |
F.H. Faulding & Co. Limited |
Analgesic pharmaceutical composition
|
|
WO1997045091A2
(en)
|
1996-05-31 |
1997-12-04 |
Euro-Celtique, S.A. |
Sustained release oxycodone formulations with no fed/fast effect
|
|
US5849800A
(en)
|
1997-03-28 |
1998-12-15 |
The Penn State Research Foundation |
Use of amantadine for treatment of Hepatitis C
|
|
FR2772615B1
(fr)
|
1997-12-23 |
2002-06-14 |
Lipha |
Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
|
|
US6007841A
(en)
|
1998-03-13 |
1999-12-28 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for treating pain
|
|
PE20000728A1
(es)
|
1998-06-26 |
2000-08-21 |
Cocensys Inc |
Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
AU2084801A
(en)
|
1999-12-09 |
2001-06-18 |
Alza Corporation |
Antiviral medication
|
|
NZ527832A
(en)
|
2001-03-13 |
2006-03-31 |
Penwest Pharmaceuticals Co |
Chronotherapeutic dosage forms
|
|
US20060198815A1
(en)
|
2001-03-19 |
2006-09-07 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
DE10129265A1
(de)
|
2001-06-18 |
2003-01-02 |
Hf Arzneimittelforsch Gmbh |
Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
|
|
IL159853A0
(en)
|
2001-07-17 |
2004-06-20 |
Teva Pharma |
Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
|
|
US20030045577A1
(en)
|
2001-08-15 |
2003-03-06 |
Madhat Maher N. |
Method for preventing infectious respiratory diseases
|
|
WO2004034963A2
(en)
|
2002-05-17 |
2004-04-29 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
US20040102525A1
(en)
|
2002-05-22 |
2004-05-27 |
Kozachuk Walter E. |
Compositions and methods of treating neurological disease and providing neuroprotection
|
|
WO2003101458A1
(en)
|
2002-05-31 |
2003-12-11 |
H. Lundbeck A/S |
A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
|
|
AU2003260336C1
(en)
|
2002-07-29 |
2008-05-29 |
Glaxo Group Limited |
Sustained release formulations comprising lamotrigine
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
KR100777904B1
(ko)
|
2002-10-24 |
2007-11-28 |
메르츠 파마 게엠베하 운트 코. 카가아 |
1-아미노시클로헥산 유도체 및 아세틸콜린에스테라제 저해제를 포함하는 약학적 제품 및 이를 이용한 복합 치료
|
|
US20040132826A1
(en)
|
2002-10-25 |
2004-07-08 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
US20060024366A1
(en)
|
2002-10-25 |
2006-02-02 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
EP1572164A2
(en)
|
2002-12-18 |
2005-09-14 |
Pain Therapeutics, Inc. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
|
AR043467A1
(es)
|
2003-03-05 |
2005-07-27 |
Osmotica Argentina S A |
Combinacion de drogas para la disfuncion motora en la enfermedad de parkinson
|
|
EA200600598A1
(ru)
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
|
AU2004273958A1
(en)
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
|
CN1870984A
(zh)
|
2003-10-22 |
2006-11-29 |
莫茨药物股份两合公司 |
1－氨基环己烷衍生物用于调节淀粉样病变中原纤维生成Aβ肽的沉积的用途
|
|
US20050119249A1
(en)
|
2003-12-02 |
2005-06-02 |
Erik Buntinx |
Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
WO2005072125A2
(en)
|
2004-01-16 |
2005-08-11 |
Massachusetts Institute Of Technology |
Composite materials for controlled release of water soluble products
|
|
WO2005072705A1
(en)
|
2004-01-29 |
2005-08-11 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
|
|
CA2556214A1
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
WO2005079851A2
(en)
|
2004-02-18 |
2005-09-01 |
Sepracor, Inc. |
Dopamine-agonist combination therapy with sedatives for improving sleep quality
|
|
TW200531680A
(en)
|
2004-03-03 |
2005-10-01 |
Merz Pharma Gmbh & Co Kgaa |
Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
|
|
CA2569015A1
(en)
|
2004-06-17 |
2006-01-26 |
Forest Laboratories, Inc. |
Modified release formulation of memantine
|
|
JP2006079138A
(ja)
|
2004-09-07 |
2006-03-23 |
Ricoh Co Ltd |
ステータス取得方法、プリンタドライバ及び情報処理装置
|
|
US20190008799A1
(en)
|
2004-11-23 |
2019-01-10 |
Adamas Pharma, Llc |
Composition for administering an nmda receptor antagonist to a subject
|
|
EP1827385B1
(en)
|
2004-11-23 |
2013-03-27 |
Adamas Pharmaceuticals, Inc. |
Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
US8389578B2
(en)
|
2004-11-24 |
2013-03-05 |
Adamas Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
|
US20190328684A1
(en)
|
2004-11-24 |
2019-10-31 |
Adamas Pharma, Llc |
Composition and method for treating neurological disease
|
|
US8252331B2
(en)
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
|
AR053986A1
(es)
*
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
|
US20080279819A1
(en)
|
2005-02-15 |
2008-11-13 |
Adamas Pharmaceuticals, Inc. |
Combinations Therapy for Treatment of Demyelinating Conditions
|
|
JP5666087B2
(ja)
|
2005-04-06 |
2015-02-12 |
アダマス・ファーマシューティカルズ・インコーポレーテッド |
Ｃｎｓ関連疾患の治療のための方法及び組成物
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
WO2007036952A2
(en)
|
2005-07-01 |
2007-04-05 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
|
US20080248107A1
(en)
|
2005-08-24 |
2008-10-09 |
Rubicon Research Pvt. Ltd. |
Controlled Release Formulation
|
|
WO2007056424A2
(en)
|
2005-11-07 |
2007-05-18 |
Penwest Pharmaceuticals, Co. |
Controlled-release emulsion compositions
|
|
US20080089861A1
(en)
|
2006-07-10 |
2008-04-17 |
Went Gregory T |
Combination therapy for treatment of demyelinating conditions
|
|
KR101575679B1
(ko)
|
2006-08-30 |
2015-12-08 |
자고텍 아게 |
코어 및 하나 이상의 배리어 층을 포함하는 방출 제어형 경구 투여 제제
|
|
EP1961414A1
(en)
|
2007-02-21 |
2008-08-27 |
FUJIFILM Manufacturing Europe B.V. |
A controlled release composition comprising a recombinant gelatin
|
|
US8779090B2
(en)
*
|
2007-02-26 |
2014-07-15 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
|
US7981930B2
(en)
|
2007-03-13 |
2011-07-19 |
Adamas Pharmaceuticals, Inc. |
Compositions and kits for treating influenza
|
|
EP2322168A1
(en)
|
2007-04-02 |
2011-05-18 |
Parkinson's Institute |
Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
|
|
EP1987815A1
(en)
|
2007-05-04 |
2008-11-05 |
Schwarz Pharma Ag |
Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
|
|
CA2689101C
(en)
|
2007-05-30 |
2013-01-22 |
Neos Therapeutics, Lp |
Modifying drug release in suspensions of ionic resin systems
|
|
US8247438B2
(en)
*
|
2008-02-27 |
2012-08-21 |
Neuropill, Inc. |
Methods for treating schizophrenia
|
|
AU2009281537A1
(en)
|
2008-08-14 |
2011-06-30 |
Bioneer A/S |
Coated tablets with a remaining degradation surface over the time
|
|
US20100221328A1
(en)
*
|
2008-12-31 |
2010-09-02 |
Wertz Christian F |
Sustained-release formulations
|
|
US20130059008A1
(en)
|
2009-01-23 |
2013-03-07 |
Jeffrey L. Atkinson |
Drying methods for tuning microparticle properties
|
|
SI2408436T1
(sl)
|
2009-03-18 |
2017-06-30 |
Evonik Roehm Gmbh |
Farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola, ki uporablja oplaščenje, ki vsebuje nevtralne vinil polimere in ekscipiente
|
|
CA2756386C
(en)
|
2009-03-23 |
2019-01-15 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
WO2010115015A1
(en)
|
2009-04-03 |
2010-10-07 |
Coating Place, Inc. |
Modified-release pharmaceutical drug composition
|
|
MX365650B
(es)
|
2009-12-02 |
2019-06-10 |
Adamas Pharmaceuticals Inc |
Composiciones de amantadina y metodos para su uso.
|
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
|
US8895662B2
(en)
|
2010-12-31 |
2014-11-25 |
Eternal Chemical Co., Ltd. |
Curable composition and method for manufacturing the same
|
|
US20130236544A1
(en)
*
|
2012-03-08 |
2013-09-12 |
Dr. Reddy's Laboratories Ltd. |
Stable pharmaceutical compositions of fesoterodine
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
PT3215132T
(pt)
|
2014-11-04 |
2021-05-07 |
Adamas Pharmaceuticals Inc |
Amantadina para melhorar a marcha em esclerose múltipla
|
|
GB201516037D0
(en)
|
2015-09-10 |
2015-10-28 |
Agco Int Gmbh |
Vehicle axel assembly
|
|
CA3072764A1
(en)
|
2017-08-24 |
2019-02-28 |
Adamas Pharma, Llc |
Amantadine compositions, preparations thereof, and methods of use
|